Towards Lipidomics of Low-Abundant Species for Exploring Tumor Heterogeneity Guided by High-Resolution Mass Spectrometry Imaging
Many studies have evidenced the main role of lipids in physiological and also pathological processes such as cancer, diabetes or neurodegenerative diseases. The identification and the in situ localization of specific low-abundant lipid species involved in cancer biology are still challenging for bot...
Main Authors: | Jonathan Cimino, David Calligaris, Johann Far, Delphine Debois, Silvia Blacher, Nor Eddine Sounni, Agnès Noel, Edwin De Pauw |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/14/12/24560 |
Similar Items
-
Mass Spectrometry Based Lipidomics: An Overview of Technological Platforms
by: Harald C. Köfeler, et al.
Published: (2012-01-01) -
Lipidomics of Glycosphingolipids
by: Hany Farwanah, et al.
Published: (2012-02-01) -
Shotgun lipidomics of phosphoethanolamine-containing lipids in biological samples after one-step in situ derivatization
by: Xianlin Han, et al.
Published: (2005-07-01) -
Accurate Quantification of Lipid Species by Electrospray Ionization Mass Spectrometry — Meets a Key Challenge in Lipidomics
by: Kui Yang, et al.
Published: (2011-11-01) -
Lipidome of Atherosclerotic Plaques from Hypercholesterolemic Rabbits
by: Lazar A. Bojic, et al.
Published: (2014-12-01)